The Blog

Have COVID, or live with someone who has COVID?

Lightship is looking for people who have recently tested positive for COVID-19 or are living with someone who has recently tested positive for COVID-19 to take part in a groundbreaking study.
Qualified participants may receive:
  • Compensation up to $430 for COVID-positive patients or up to $380 for household members
  • Study-related care from the convenience of your home at no cost to you
  • Access to health specialists
  • Health insurance is not required



Right now, a research study is testing an oral investigational medication that may help reduce the symptoms and severity of COVID-19. If you have tested positive for COVID-19 within the past 5 days and are experiencing symptoms, or you live with someone who recently tested positive for COVID-19 but you are not positive or experiencing symptoms, you may be a good candidate for this study. There is no cost or obligation to participate, and you can take part from the comfort of your home.

Study Details:

  • Male or Female
  • Over 18 years old
  • Either you have been diagnosed with COVID-19 within the past 5 days and are experiencing symptoms OR you do not have COVID-19 but you live with someone who has tested positive in the past 4 days and has symptoms
  • Has not previously had a COVID-19 infection
Let's get started

Why Participate in Clinical Trials

Clinical research helps find better ways to prevent, screen for, diagnose, or treat diseases and other health conditions. They involve people just like you, who are motivated to take part to help doctors and researchers learn more about diseases and improve health care for everyone.

About Lightship

At Lightship, we engage patients at home and on their schedule to make taking part in clinical research more accessible for everyone. We use everyday solutions such as video communication to allow patients to interact with our doctors, nurses, and study coordinators throughout the study. At Lightship, we make every effort to be the best provider of direct to patient clinical research in the United States.